Table 4.
VYC-15L (N = 103) | |
---|---|
Baseline AIHS, no. (%) | |
Moderate | 34/39 (87.2) |
Severe | 50/62 (80.6) |
Treatment volume, no. (%) | |
≤Mediana | 46/51 (90.2) |
>Median | 38/50 (76.0) |
Injection instrument | |
27G 1½-inch cannula | 52/56 (90.2) |
32G ½-inch needle | 32/45 (71.1) |
AIHS, Allergan Infraorbital Hollow Scale; mITT, modified intent-to-treat; VYC-15L, Juvéderm Volbella XC.
aMedian total volume injected for initial and touch-up treatments combined was 1.0 mL (range, 0.2-2.2 mL) for the left side and 1.0 mL (range, 0.1-2.2 mL) for the right side, with a total median of 1.5 mL (0.7 mL each side) for initial treatment and 1.0 mL (0.5 mL each side) for touch-up treatment.